Arcosa (ACA)
(Real Time Quote from BATS)
$84.12 USD
-1.73 (-2.02%)
Updated Jun 6, 2024 01:58 PM ET
1-Strong Buy of 5 1
B Value D Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ACA 84.12 -1.73(-2.02%)
Will ACA be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ACA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACA
Arcosa (ACA) Upgraded to Strong Buy: Here's What You Should Know
Best Value Stocks to Buy for June 6th
ACA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Implied Volatility Surging for Arcosa (ACA) Stock Options
Quanex (NX) Gears Up to Report Q2 Earnings: What's in Store?
Zacks Industry Outlook Owens Corning, Armstrong World Industries, Knife River, Arcosa and Frontdoor
Other News for ACA
Analysts Offer Insights on Industrial Goods Companies: Core & Main (CNM), Leonardo Drs (DRS) and Arcosa (ACA)
IN BRIEF: Credit Agricole completes buy of Degroof majority stake
GLOBAL BRIEFING: Japan's trade deficit widens as imports, exports rise
Global company events calendar
Global company events calendar